A luminous glass bead at the center of concentric translucent rings

    MOTS-c

    Research-stage — not approved for human useEvidence: Mostly animal/lab studiesMetabolic Health

    A mitochondrially derived peptide studied in laboratory and animal research; not FDA-approved.

    Profile last verified 2026-08-20

    What it is

    MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA — part of a newly appreciated class of mitochondrial-derived peptides involved in metabolic signaling. As science, it is genuinely exciting; as a product, it is premature.

    The evidence is cell and animal work on exercise capacity and insulin sensitivity, plus the first small human safety studies. No approved product exists, and anything sold as MOTS-c today is a research chemical without verified contents.

    What researchers have actually studied it for

    Metabolic regulation, insulin sensitivity and exercise physiology — in cell and animal studies, with human research only beginning.

    How it works

    Encoded inside the mitochondrial genome's 12S rRNA region — part of why its 2015 discovery was startling — MOTS-c translocates to the cell nucleus under metabolic stress and activates AMPK-linked programs, acting like an exercise-mimetic signal between mitochondria and the genome.

    Where it came from

    Identified in 2015 by researchers at USC exploring 'mitochondrial-derived peptides,' a class that rewrote assumptions about what the tiny mitochondrial genome encodes. Rodent papers on exercise capacity and insulin sensitivity made it famous; first-in-human dosing studies only began years later, and the science is still young.

    What the research record actually contains

    • Rodent studies: improved insulin sensitivity, exercise capacity and diet-induced-obesity resistance.
    • Human observational work linking MOTS-c levels to metabolic states.
    • Early-phase human safety studies of analogs; no outcome trials.

    What's known about risks

    Too early to characterize — the honest and complete statement. Early human safety work exists for related analogs; the gray-market vial has none of it behind it.

    Where it stands legally

    No approval anywhere; research-chemical channel only.

    Worth asking a licensed provider

    • 1.If metabolic health is the goal, what does my current exercise, diet and lab picture say first?
    • 2.What proven interventions produce the effects MOTS-c shows in mice?
    • 3.Is there legitimate trial participation in mitochondrial-peptide research?

    MOTS-c FAQ

    More in Metabolic Health